NEW YORK, July 10, 2023 /PRNewswire/ — As per Facts and Factors study, the global Plant-based Milk market size was valued at USD 10.1 billion in 2022 and is predicted to reach a value of USD 25.3 billion by 2030 with a compound annual growth rate (CAGR) of approximately 10.2% during the…

Abbott

At Abbott, sustainability starts with our purpose — helping people lead fuller lives through better health. That’s how Abbott can make the biggest impact on people’s lives and deliver sustainable, responsible business growth in the years to come.

Our 2022 Global Sustainability Report highlights the meaningful progress we’ve made toward achieving our 2030 Sustainability Plan and demonstrates how we’re working to improve the lives of 3 billion people each year by the decade’s end.

A key strategy we’re using to reach this goal is consciously innovating for access and affordability to make our future products and technologies available to more people around the world. The Design Principles we’re integrating into our R&D processes will help us evolve the way we bring our technologies to the people who need them.

Three examples of how we’ve made our health technology more accessible, personal and convenient to more people include delivering our next-generation continuous glucose monitoring system FreeStyle Libre 3, introducing an improved version of the NeuroSphere MyPath digital health app, and launching our Panbio HIV Self-Test in 14 countries.

In addition to our progress in innovating for access and affordability, the report highlights the ways in which we’re building the diverse, innovative workforce of tomorrow, responsibly connecting data, technology and care, creating a resilient, diverse and responsible supply chain, and protecting a healthy environment.

For more details, take a look at Abbott’s 2022 Global Sustainability Report.

IMPORTANT SAFETY INFORMATION

PANBIO HIV SELF-TEST

FREESTYLE LIBRE 14 DAY, FREESTYLE LIBRE 2 AND FREESTYLE LIBRE 3 SYSTEMS

Failure to use FreeStyle Libre systems as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose reading and alarms (if enabled) do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or FreeStyleLibre.us for safety info.

*Please refer to www.freestylelibre.us for the indications and important safety information.

PANBIO HIV SELF-TEST

The Panbio Self-Test is not available in the U.S. where Abbott manufactures and sells the BinaxNOW COVID-19 Antigen Self Test which is also authorized for over-the-counter usage and available at major national pharmacies, grocery chains and retailers.

Bacardi continues to bring Shake Your Future – a free, professional bartender training program for unemployed young adults – to more people. Most recently, Bacardi partnered with the Bermuda Government’s Department of Workforce Development, to bring the program to Bermuda which is home to the global headquarters of the family-owned spirits company. Now, after undergoing rigorous training at the prestigious European Bartending School in London, followed by workshops on personal branding and marketing, participants of the transformative program have returned to Bermuda to embark on work placement opportunities with local bars and restaurants.

Originally created by Bacardi in 2018, Shake Your Future has since launched in Italy, France, India, South Africa, and other markets. Globally, an impressive 80% of graduates have secured successful careers in the hospitality industry. By providing participants with valuable skills, hands-on experience, and industry connections, Shake Your Future is helping to equip a new generation of hospitality professionals with the tools they need to succeed in this dynamic industry.

Learn more about Shake Your Future in Bermuda

About Bacardi Limited
Bacardi Limited, the largest privately held spirits company in the world, produces and markets internationally recognized spirits and wines. The Bacardi Limited brand portfolio comprises more than 200 brands and labels, including BACARDÍ® rum, GREY GOOSE® vodka, PATRÓN® tequila, DEWAR’S® Blended Scotch whisky, BOMBAY SAPPHIRE® gin, MARTINI® vermouth and sparkling wines, CAZADORES® 100% blue agave tequila, and other leading and emerging brands including WILLIAM LAWSON’S® Scotch whisky, ST-GERMAIN® elderflower liqueur, and ERISTOFF® vodka. Founded more than 161 years ago in Santiago de Cuba, family-owned Bacardi Limited currently employs more than 8,000 people, operates production facilities in 10 countries, and sells its brands in more than 170 countries. Bacardi Limited refers to the Bacardi group of companies, including Bacardi International Limited. Visit https://www.bacardilimited.com/or follow us on LinkedIn or Instagram.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.